EL
Enliven Therapeutics, Inc.
ELVN · NASDAQ
$56.23 -1.88% (-$1.08)
1M -2.92%
Market Cap $4.02B
P/E Ratio -
Div. Yield -
ROE 18.55%
Bulios Fair Price
$43.6
22.5% downside
Trenutna cena
$56.23
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica ELVN trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
44 /100
Fair P/B 4.49x
P/E N/A
EV/EBITDA N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
Book val. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
FCF margin N/A
Quality
0 /100
Poor ROIC 13.88%
ROE 18.55%
Asset turnover 0.00x
Debt
100 /100
Low Debt/Equity 0.00x
Current ratio 64.07x
Int. coverage N/A
Stability
29 /100
Unstable Beta 0.24x
EPS volatility 35.88%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o ELVN
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Richard A. Fair
Employees
67
Headquarters
Boulder
Prihajajoči dogodki
11 NOV.
Earnings
Upcoming earnings report